A 6-year study of 1,000 people aged 70–90 found no difference in rates of memory or cognition decline among participants who did or did not use statins. Read & Research Alzheimer’s More

Be the first to comment
            

We estimated the prevalence and correlates of mild cognitive impairment (MCI) among middle-aged and older diverse Hispanics/Latinos. Read & Research Alzheimer’s More

Be the first to comment
            

New research finds that people who cannot read may have a threefold risk of developing dementia in older age, compared with people who can read. Read & Research Alzheimer’s More

Be the first to comment
            

A study of 35 people with and without Alzheimer’s disease found that hyperspectral imaging of the retina could aid early diagnosis of the disease. Read & Research Alzheimer’s More

Be the first to comment
            

Why is my leg shaking?"> Why is my leg shaking?

Posted November 13, 2019 By

There are many reasons a person’s leg could be shaking, from restless legs syndrome to anxiety. Read this article to learn about 10 possible causes of a shaky leg. Read & Research Alzheimer’s More

Be the first to comment
            

In a new review of the evidence, scientists propose two main types of Parkinson’s, depending on which part of the nervous system the disease originates in. Read & Research Alzheimer’s More

Be the first to comment
            

New research examines the cognitive ability of children in the hope that markers of cognitive decline will predict dementia later in life. Read & Research Alzheimer’s More

Be the first to comment
            

The effect of comorbid cardiometabolic diseases (CMDs), including diabetes, heart diseases, and stroke, on dementia remains unclear. Read & Research Alzheimer’s More

Be the first to comment
            

Development of disease-modifying treatments for Alzheimer’s disease (AD) has been challenging, with no drugs approved to date. The failures of several amyloid-targeted programs have led many to dismiss the amyloid beta (Aβ) hypothesis of AD. An antiamyloid antibody aducanumab recently showed modest but significant efficacy in a phase 3 trial, Read & Research Alzheimer’s More

Be the first to comment
            

The first large-scale study of its kind examines the link between waist circumference in later life and the risk of developing dementia. Read & Research Alzheimer’s More

Be the first to comment
            

A new study shows, for the first time, that cerebrospinal fluid washes into and out of the brain in waves during sleep, helping clear out waste. Read & Research Alzheimer’s More

Be the first to comment
            

Multidomain intervention for Alzheimer’s disease (AD) risk reduction is an emerging therapeutic paradigm. Read & Research Alzheimer’s More

Be the first to comment
            

The levels and distribution of amyloid deposits in the brain does not correlate well with Alzheimer’s disease (AD) progression. Therefore, it is likely that amyloid precursor protein and its proteolytic fragments other than amyloid β (Aβ) contribute to the onset of AD. Read & Research Alzheimer’s More

Be the first to comment
            

Odor identification deficits characterize Alzheimer’s disease and other dementias. We examined if intact performance on brief cognitive and odor identification tests predicts lack of transition to dementia. Read & Research Alzheimer’s More

Be the first to comment
            

This study aimed to determine if later birth year influences trajectory of age-related cognitive decline across racial/ethnic groups and to test whether years of school, childhood socioeconomic status, and cardiovascular disease burden explain such secular trends. Read & Research Alzheimer’s More

Be the first to comment
            

Differential patterns of brain atrophy on structural magnetic resonance imaging (MRI) revealed four reproducible subtypes of Alzheimer’s disease (AD): (1) “typical”, (2) “limbic-predominant”, (3) “hippocampal-sparing”, and (4) “mild atrophy”. We examined the neurobiological characteristics and clinical progression of these atrophy-defined subtypes. Read & Research Alzheimer’s More

Be the first to comment
            

A new study of 1,628 older people living in Japan found a 52–74% higher chance of developing dementia in those with higher blood levels of trans fats. Read & Research Alzheimer’s More

Be the first to comment
            

New research in mice sheds light on the mechanism that explains the causal link between a diet high in salt and a marker of Alzheimer’s disease. Read & Research Alzheimer’s More

Be the first to comment
            

Synaptic damage, axonal neurodegeneration, and neuroinflammation are common features in Alzheimer’s disease (AD), frontotemporal dementia (FTD), and Creutzfeldt-Jakob disease (CJD). Read & Research Alzheimer’s More

Be the first to comment
            

Alzheimer’s disease (AD) is linked to neuronal calcium dyshomeostasis, which is associated with network hyperexcitability. Decreased expression of the calcium-binding protein calbindin-D28K (CB) might be a susceptibility factor for AD. The subiculum is affected early in AD, for unknown reasons. Read & Research Alzheimer’s More

Be the first to comment
            

What is apraxia?"> What is apraxia?

Posted October 24, 2019 By

Apraxia is a neurological disorder that affects a person’s ability to perform everyday movements. Learn more about the symptoms, causes, and types in this article. Read & Research Alzheimer’s More

Be the first to comment
            

Biotech company Biogen have announced that they will file for official approval of a new Alzheimer’s drug, while results in clinical trials were uncertain. Read & Research Alzheimer’s More

Be the first to comment
            

Frontotemporal lobar degeneration (FTLD) is the most common form of dementia for those under 60 years of age. Increasing numbers of therapeutics targeting FTLD syndromes are being developed. Read & Research Alzheimer’s More

Be the first to comment
            

Sensor-based assessment of challenging behaviors in dementia may be useful to support caregivers. Here, we investigated accelerometry as tool for identification and prediction of challenging behaviors. Read & Research Alzheimer’s More

Be the first to comment
            

Understanding the heterogeneous pathology in Alzheimer’s disease and related tauopathies is one of the most urgent and fundamental challenges facing the discovery of novel disease-modifying therapies. Through monitoring ensembles of toxic and nontoxic tau oligomers spontaneously formed in cells, our biosensor technology can identify tool compounds that modulate tau oligomer Read & Research Alzheimer’s More

Be the first to comment
            

A new study in twins finds that modifiable factors, such as early family life, may be more important than genes in driving heart and brain health outcomes. Read & Research Alzheimer’s More

Be the first to comment
            

It is important to establish the natural history of familial frontotemporal lobar degeneration (f-FTLD) and provide clinical and biomarker data for planning these studies, particularly in the asymptomatic phase. Read & Research Alzheimer’s More

Be the first to comment
            

Multiple immunity biomarkers have been suggested as tracers of neuroinflammation in neurodegeneration. This study aimed to verify findings in cerebrospinal fluid (CSF) samples of Alzheimer’s disease (AD) and Parkinson’s disease (PD) subjects from the network of the European, Innovative Medicines Initiative–funded project AETIONOMY. Read & Research Alzheimer’s More

Be the first to comment
            

New research shows how frontotemporal dementia progresses and enables scientists to accurately predict how the condition will spread. Read & Research Alzheimer’s More

Be the first to comment
            

A new study finds that testing memory with sex-specific scores could lead to more females and fewer males receiving a mild cognitive impairment diagnosis. Read & Research Alzheimer’s More

Be the first to comment